Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

177 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cost-effectiveness of percutaneous coronary intervention with cobalt-chromium everolimus eluting stents versus bare metal stents: Results from a patient level meta-analysis of randomized trials.
Ferko N, Ferrante G, Hasegawa JT, Schikorr T, Soleas IM, Hernandez JB, Sabaté M, Kaiser C, Brugaletta S, de la Torre Hernandez JM, Galatius S, Cequier A, Eberli F, de Belder A, Serruys PW, Valgimigli M. Ferko N, et al. Among authors: galatius s. Catheter Cardiovasc Interv. 2017 May;89(6):994-1002. doi: 10.1002/ccd.26700. Epub 2016 Aug 16. Catheter Cardiovasc Interv. 2017. PMID: 27527508 Free PMC article.
Drug-eluting or bare-metal stents for large coronary vessel stenting? The BASKET-PROVE (PROspective Validation Examination) trial: study protocol and design.
Pfisterer M, Bertel O, Bonetti PO, Brunner-La Rocca HP, Eberli FR, Erne P, Galatius S, Hornig B, Kiowski W, Pachinger O, Pedrazzini G, Rickli H, De Servi S, Kaiser C; BASKET-PROVE Investigators. Pfisterer M, et al. Among authors: galatius s. Am Heart J. 2008 Apr;155(4):609-14. doi: 10.1016/j.ahj.2007.11.011. Epub 2008 Feb 21. Am Heart J. 2008. PMID: 18371466 Clinical Trial.
Drug-eluting versus bare-metal stents in large coronary arteries.
Kaiser C, Galatius S, Erne P, Eberli F, Alber H, Rickli H, Pedrazzini G, Hornig B, Bertel O, Bonetti P, De Servi S, Brunner-La Rocca HP, Ricard I, Pfisterer M; BASKET–PROVE Study Group. Kaiser C, et al. Among authors: galatius s. N Engl J Med. 2010 Dec 9;363(24):2310-9. doi: 10.1056/NEJMoa1009406. Epub 2010 Nov 16. N Engl J Med. 2010. PMID: 21080780 Free article. Clinical Trial.
Improved outcomes of elderly patients treated with drug-eluting versus bare metal stents in large coronary arteries: results from the BAsel Stent Kosten-Effektivitäts Trial PROspective Validation Examination randomized trial.
Kurz DJ, Bernheim AM, Tüller D, Zbinden R, Jeger R, Kaiser C, Galatius S, Hansen KW, Alber H, Pfisterer M, Eberli FR. Kurz DJ, et al. Among authors: galatius s. Am Heart J. 2015 Oct;170(4):787-795.e1. doi: 10.1016/j.ahj.2015.07.009. Epub 2015 Jul 17. Am Heart J. 2015. PMID: 26386803 Clinical Trial.
Improved two-year outcomes after drug-eluting versus bare-metal stent implantation in women and men with large coronary arteries: importance of vessel size.
Hansen KW, Kaiser C, Hvelplund A, Soerensen R, Madsen JK, Jensen JS, Pedersen SH, Eberli FR, Erne P, Alber H, Pfisterer M, Galatius S; BASKET PROVE Investigators. Hansen KW, et al. Among authors: galatius s. Int J Cardiol. 2013 Oct 25;169(1):29-34. doi: 10.1016/j.ijcard.2013.08.091. Epub 2013 Sep 8. Int J Cardiol. 2013. PMID: 24063913 Clinical Trial.
Long-term benefits and risks of drug-eluting compared to bare-metal stents in patients with versus without chronic kidney disease.
Wanitschek M, Pfisterer M, Hvelplund A, De Servi S, Bertel O, Jeger R, Rickenbacher P, Iversen A, Jensen JS, Galatius S, Kaiser C, Alber H; BASKET-PROVE Investigators. Wanitschek M, et al. Among authors: galatius s. Int J Cardiol. 2013 Oct 3;168(3):2381-8. doi: 10.1016/j.ijcard.2013.01.257. Epub 2013 Feb 27. Int J Cardiol. 2013. PMID: 23453439 Clinical Trial.
Can the optimal type of stent be predicted based on clinical risk factors? A subgroup analysis of the randomized BASKET-PROVE trial.
Vassalli G, Klersy C, De Servi S, Galatius S, Erne P, Eberli F, Rickli H, Hornig B, Bertel O, Bonetti P, Moccetti T, Kaiser C, Pfisterer M, Pedrazzini G; BASKET-PROVE Investigators. Vassalli G, et al. Among authors: galatius s. Am Heart J. 2016 Mar;173:1-7. doi: 10.1016/j.ahj.2015.11.007. Epub 2015 Dec 1. Am Heart J. 2016. PMID: 26920590 Clinical Trial.
Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivitäts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial.
Kaiser C, Galatius S, Jeger R, Gilgen N, Skov Jensen J, Naber C, Alber H, Wanitschek M, Eberli F, Kurz DJ, Pedrazzini G, Moccetti T, Rickli H, Weilenmann D, Vuillomenet A, Steiner M, Von Felten S, Vogt DR, Wadt Hansen K, Rickenbacher P, Conen D, Müller C, Buser P, Hoffmann A, Pfisterer M; BASKET-PROVE II study group. Kaiser C, et al. Among authors: galatius s. Circulation. 2015 Jan 6;131(1):74-81. doi: 10.1161/CIRCULATIONAHA.114.013520. Epub 2014 Nov 19. Circulation. 2015. PMID: 25411159 Clinical Trial.
177 results